Kwality Pharmaceuticals Ltd
BSE: 539997
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 162.35+3.5% | 156.82+27.0% | 123.44+10.9% | 111.31-0.1% | 111.48-3.6% | 115.68+37.0% | 84.41-6.2% | 90.03 |
| Other Income | 0.62-41.1% | 1.06+100.5% | 0.53-41.2% | 0.90+138.8% | 0.38-50.9% | 0.77+16.8% | 0.66+195.0% | 0.22 |
| Total Income | 162.97+3.2% | 157.88+27.4% | 123.97+10.5% | 112.21+0.3% | 111.85-3.9% | 116.44+36.9% | 85.06-5.8% | 90.26 |
| EXPENSES | ||||||||
| Expenditure | 128.98+2.2% | 126.23+25.2% | 100.79+7.5% | 93.76-1.1% | 94.81-2.6% | 97.35+32.2% | 73.65-5.2% | 77.67 |
| Tax | 8.36+31.6% | 6.36+0.2% | 6.35+46.4% | 4.33-15.1% | 5.11+11.2% | 4.59+60.0% | 2.87-29.9% | 4.10 |
| PROFIT | ||||||||
| PBT | 33.99+7.4% | 31.65+41.6% | 22.35+21.1% | 18.45+8.3% | 17.04-10.8% | 19.09+67.3% | 11.41-9.3% | 12.58 |
| Net Profit | 25.63+1.3% | 25.29+58.0% | 16.01+13.4% | 14.12+18.3% | 11.93-17.7% | 14.50+69.8% | 8.54+0.6% | 8.48 |
| KEY METRICS | ||||||||
| OPM % | 25.27%+0.57pp | 24.70%+1.11pp | 23.59%+0.81pp | 22.78%+1.09pp | 21.69%-0.70pp | 22.39%+17.64pp | 4.75%-0.85pp | 5.60% |
| NPM % | 15.72%-0.30pp | 16.02%+3.11pp | 12.91%+0.33pp | 12.58%+1.91pp | 10.67%-1.78pp | 12.45%+2.41pp | 10.04%+0.64pp | 9.40% |
| EPS | 24.70+1.4% | 24.37+57.9% | 15.43+13.5% | 13.60+18.3% | 11.50-17.7% | 13.97+69.7% | 8.23+0.6% | 8.18 |
Corporate Events
Board MeetingKPL
202631Aug
Board Meeting
The 43rd Annual General Meeting (AGM) of the Shareholders of…
BSE Filing ↗ Board MeetingKPL
202610Aug
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗ Board MeetingKPL
202630Jun
Board Meeting
The Board of Directors considered and approved the standalon…
BSE Filing ↗ Board MeetingKPL
202423May
Board Meeting
Consider and approve the Standalone & Consolidated audited f…
BSE Filing ↗ Board MeetingKPL
20246Feb
Board Meeting
Consider and approve Standalone and Consolidated Unaudited F…
BSE Filing ↗ Board MeetingKPL
20234Nov
Board Meeting
Consider and approve the Unaudited Standalone and Consolidat…
BSE Filing ↗ Board MeetingKPL
202310Aug
Board Meeting
Consider and approve the Standalone and Consolidated Unaudit…
BSE Filing ↗